Back to the Top
I want to know or more about the enterohepatic circle and all factors
than
could influence in the intensify, time, and appearance the double peak.
I have data in dogs after oral administration, where in same time could
be
appear the double peak more clear, and in other cases ( after single or
repeated dose) in the same animal, not is possible to observe any peak.
And in same animal yes and in other not.
The questions is:, are there very important biopharmaceutical factors
(intraday) that can explain a very great variability in a enterohepatic
circle, not related with interindividual variability, dose or
formulation?
Thank you
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)